跳至主要内容
临床试验/NCT02069665
NCT02069665已完成不适用

Assessing the Effectiveness of Integrative Treatment That Combines Interior and Exterior Treatment Plans in Pediatric Pneumonia: a Program by PRC National Clinical Research Base of Traditional Chinese Medicine for Major Diseases

Liaoning University of Traditional Chinese Medicine6 个研究点 分布在 1 个国家目标入组 451 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
451
试验地点
6
主要终点
Cured rate

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of traditional Chinese medicine for treatment of pediatric pneumonia. It is a multicenter randomized controlled trial.

详细描述

The retrospective case study has been finished at the National clinical research base of traditional Chinese medicine for major disease pediatric pneumonia, and the research center organized the field training of prospective-study to coordinated units. Based on the primary statistical outcomes of retrospective case study and the discussion around prospective-study during the training, investigators found it difficult to include simplex viral infection, therefore, investigators revised the inclusion criteria and treatment protocol of the pragmatic randomized controlled trial.

The block randomization is used in this trial. Random numbers are generated by SPSS software. Statistical analysis staff and those who perform the follow-up are blinded. Sample size calculation was performed, which was 369, and considering drop-out or withdrawal, investigators plan to enroll 450 patients (300 in experimental group, 150 in control).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
6 Months 至 59 Months(Child)
性别
All
接受健康志愿者

入选标准

  • children, aged 6 months to 59 months old, diagnosed as pneumonia according to western medicine diagnostic criteria;
  • diagnosed as TCM pneumonia with gasp-cough, meeting wind-heat blocking lungs pattern (feng re bi fei zheng), and phlegm-heat blocking lungs pattern (tan re bi fei zheng);
  • disease progression within 72 hours;
  • those whose guardians understood and assigned the informed consent;

排除标准

  • emergency pneumonia;
  • complicated with other Pulmonary Disorders attack other than pneumonia;
  • complicated with primary disease of heart (congenital heart disease, myocarditis, et al), liver (ALT, and AST ≥ 1.5 times of normal value ceiling), kidney (BUN > 8.2mmol/L, or serum CR > 104 µmol/L, et al) and blood system (anemia), and those with psychopathy;
  • allergic to interventional medications;
  • those who are participating or have participated in other clinical trials in 3 months.

研究组 & 干预措施

Injection, medications and application

Experimental

Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;

Medications: according to TCM syndrome differentiations;

  • Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)
  • Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)

External application: Fuxiong San

干预措施: Fuxiong San (Other)

Injection, medications and application

Experimental

Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;

Medications: according to TCM syndrome differentiations;

  • Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)
  • Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)

External application: Fuxiong San

干预措施: Xiyanping injection (Drug)

Injection, medications and application

Experimental

Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;

Medications: according to TCM syndrome differentiations;

  • Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)
  • Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)

External application: Fuxiong San

干预措施: Xiaoer Qingfei Heji (mixture) (Drug)

Injection, medications and application

Experimental

Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;

Medications: according to TCM syndrome differentiations;

  • Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)
  • Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)

External application: Fuxiong San

干预措施: Zhi Ke San (Drug)

Injection, medications and application

Experimental

Intravenous injection: Xiyanping injection, produced by Jiangxi Qing Feng Pharmaceutical Co., Ltd;

Medications: according to TCM syndrome differentiations;

  • Wind-heat blocking lungs pattern (feng re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Zhi Ke San (herbal powder to relieve cough)
  • Phlegm-heat blocking lungs pattern (tan re bi fei zheng): Xiaoer Qingfei Heji (mixture), and Hua Tan San (herbal powder to remove phlegm)

External application: Fuxiong San

干预措施: Hua Tan San (Drug)

Injection and medications

Active Comparator

Intravenous injection: Ribavirin Injection;

Medications: symptomatic therapies

  • Guaifenesin Syrup, for removing phlegm, relieving gasp-cough;
  • Ibuprofen Suspension, and salbutamol in case of different symptoms

干预措施: Ribavirin Injection (Drug)

Injection and medications

Active Comparator

Intravenous injection: Ribavirin Injection;

Medications: symptomatic therapies

  • Guaifenesin Syrup, for removing phlegm, relieving gasp-cough;
  • Ibuprofen Suspension, and salbutamol in case of different symptoms

干预措施: Guaifenesin Syrup (Drug)

Injection and medications

Active Comparator

Intravenous injection: Ribavirin Injection;

Medications: symptomatic therapies

  • Guaifenesin Syrup, for removing phlegm, relieving gasp-cough;
  • Ibuprofen Suspension, and salbutamol in case of different symptoms

干预措施: Ibuprofen Suspension (Drug)

Injection and medications

Active Comparator

Intravenous injection: Ribavirin Injection;

Medications: symptomatic therapies

  • Guaifenesin Syrup, for removing phlegm, relieving gasp-cough;
  • Ibuprofen Suspension, and salbutamol in case of different symptoms

干预措施: salbutamol (Drug)

结局指标

主要结局

Cured rate

时间窗: Every day since receiving treatment, all together 10 days (times)

Clinical symptoms and signs totally disappear, the period of lab tests return to normal is recorded.

Effectiveness time window

时间窗: Every day since receiving treatment, all together 10 days (times)

days range from treatment is received to the effectiveness is observed, and symptoms disappear

次要结局

  • TCM syndrome scores and effective rate(10 days)
  • Effect in fever, cough, phlegm and gasp(10 days)
  • Time of lung rales disappear completely(10 days)
  • Check-out time(10 days)
  • Pulmonary disease incidence(30 days)

研究者

发起方
Liaoning University of Traditional Chinese Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xuefeng Wang

Chief physician

Liaoning University of Traditional Chinese Medicine

研究点 (6)

Loading locations...

相似试验

Effectiveness Study of Integrative Treatment for... | 临床试验